Ovarian cancer surgery: bowel shaving vs bowel resection
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial compares two surgical options for ovarian cancer that involves the rectosigmoid bowel wall: removing a segment (resection) versus shaving only the involved layer (tumor shaving). It may help find which approach is safer and better for people whose cancer has spread to the outer bowel layers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have epithelial ovarian cancer (not a non-epithelial type).
- A colonoscopy showed no cancer on the bowel lining (mucosa).
- During surgery, doctors find tumor spread into the bowel wall’s outer layers (serosal or seromuscular), not just the lining.
- Your health ability is fairly good (ECOG is less than 3).
- You have acceptable surgical risk (ASA score is less than 3; usually ASA 0–2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two surgical approaches for removing advanced ovarian cancer that has attached to the rectosigmoid (lower bowel). Both methods aim to remove the cancer safely, but this trial tests whether one approach works as well as the other.
This trial studies how patients’ day-to-day quality of life changes after a specific type of rectal/low anterior resection during treatment for advanced ovarian cancer. It may help the medical team understand what symptoms and recovery needs to expect after surgery.
This trial compares different surgical approaches for women with rectal cancer who are scheduled for a specific type of laparoscopic surgery. It aims to find which approach works best.
This trial compares surgical techniques for removing rectal cancer (anterior resection). It looks at patients with adenocarcinoma who are scheduled for surgery to find the best approach.
This study explores an alternative method to the previous approach of whether to bypass or not? or wait... it's about the use of something? wait... the title is... wait? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? title? you get the idea? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?until? ?title? ?title? ?title? ?title? ?title? flask? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ? what? ?title? ?title? ?title? ?title? ?title? ?title? ?title? ? ???????????????
This trial tests whether using a small-scope (minimally invasive) surgery instead of a large incision can safely remove remaining ovarian cancer after chemotherapy. It may mean a faster recovery and fewer complications.
Hear when a new Epithelial Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.